EC Number   |
Expression |
Reference |
|---|
   3.4.22.56 | down |
astaxanthine at 0.1 mM protects PC12 cells from damaging effects of beta-amyloid peptide 25-35 by partially down-regulating the activation of caspase 3 |
709483 |
| 3.4.22.56 | down |
crude Silybum marianum extract treatments significantly lower activation of procaspase-3 to active caspase-3 |
708447 |
| 3.4.22.56 | down |
following prolonged epileptic seizures, a mild as well as a severe insult produces caspase-3-negative necrotic neurons |
710105 |
| 3.4.22.56 | down |
serum caspase-3 decreases 5.8 times in rats with human umbilical cord mesenchymal stem cells transplantated via the left carotid artery compared to control groups |
707825 |
| 3.4.22.56 | down |
sesamol treatment significantly and dose-dependently inhibits caspase-3 activity in streptozotocin-injected rats |
709663 |
| 3.4.22.56 | up |
0.05 mM lunasin-induced apoptosis increases caspase-3 activity by 77% |
707972 |
| 3.4.22.56 | up |
administration of ethanol induces a transient increase of the expression of caspase-3 which can be partially blocked by the pituitary adenylate cyclase-activating polypeptide |
710123 |
| 3.4.22.56 | up |
amifostine increases caspase-3 expression |
710058 |
| 3.4.22.56 | up |
caspase-3 activity in gastric mucosa shows 2.5fold increase in non-diabetic rats that receive indomethacin, 3.5fold increase in diabetic indomethacin-treated rats, and 1fold-increase in diabetic telmisartan-treated rats that receive indomethacin as compared to the control group |
708405 |
| 3.4.22.56 | up |
caspase-3 levels are significantly elevated in the diabetic rat sciatic nerve |
709663 |
